You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cemiplimab

Showing 1 - 25 of 115
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Trial (Cemiplimab)

Available
    • Cemiplimab
    • (no location specified)
    Nov 9, 2023

    Metastatic Uveal Melanoma Trial in Tampa (ZIV-Aflibercept, Cemiplimab)

    Recruiting
    • Metastatic Uveal Melanoma
    • Tampa, Florida
      Moffitt Cancer Center
    Nov 2, 2023

    Locally Advanced Basal Cell Carcinoma Trial in Philadelphia (biological, procedure, other)

    Not yet recruiting
    • Locally Advanced Basal Cell Carcinoma
    • Cemiplimab
    • +3 more
    • Philadelphia, Pennsylvania
      Thomas Jefferson University Hospital
    Jun 28, 2023

    NSCLC Trial (Dupilumab, Cemiplimab)

    Not yet recruiting
    • Non-Small Cell Lung Cancer
    • Dupilumab
    • Cemiplimab
    • (no location specified)
    Oct 12, 2023

    Colon Cancer Trial in Houston (Cemiplimab)

    Not yet recruiting
    • Colon Cancer
    • Cemiplimab
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 18, 2023

    Advanced NSCLC Trial (fianlimab, cemiplimab, Placebo)

    Not yet recruiting
    • Advanced Non-Small Cell Lung Cancer
    • (no location specified)
    Mar 27, 2023

    NSCLC Trial (fianlimab, cemiplimab, Pemetrexed)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • (no location specified)
    Mar 23, 2023

    Advanced NSCLC Trial (BNT116, Cemiplimab)

    Not yet recruiting
    • Advanced Non-Small Cell Lung Cancer
    • (no location specified)
    Jan 3, 2023

    Cutaneous Squamous Cell Carcinoma, Squamous Cell Carcinoma, Advanced Squamous Cell Carcinoma Trial in Miami (Cemiplimab-Rwlc,

    Not yet recruiting
    • Cutaneous Squamous Cell Carcinoma
    • +2 more
    • Miami, Florida
      Miami Cancer Institute at Baptist Health, Inc.
    Feb 6, 2023

    Metastatic Lung Non-Small Cell Carcinoma, Metastatic Malignant Tumor in the Brain, Stage IV Lung Cancer AJCC v8 Trial in Duarte

    Not yet recruiting
    • Metastatic Lung Non-Small Cell Carcinoma
    • +2 more
    • Biospecimen Collection
    • +4 more
    • Duarte, California
      City of Hope Medical Center
    May 1, 2023

    Cutaneous Squamous Cell Carcinoma, Advanced Cancer Trial in Boston (Cemiplimab, Everolimus, Sirolimus)

    Recruiting
    • Cutaneous Squamous Cell Carcinoma
    • Advanced Cancer
    • Cemiplimab
    • +3 more
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Jan 19, 2023

    Hormone Receptor-positive Breast Cancer Trial in Tampa (Cemiplimab, Capecitabine)

    Recruiting
    • Hormone Receptor-positive Breast Cancer
    • Tampa, Florida
      Moffitt Cancer Center
    Dec 30, 2022

    Melanoma Trial in Knoxville (Fianlimab, Cemiplimab, Pembrolizumab)

    Recruiting
    • Melanoma
    • Knoxville, Tennessee
      University of Tennessee Medical Center
    Dec 20, 2022

    Glioblastoma, Recurrent Glioblastoma Trial in United States (ASP8374, cemiplimab)

    Active, not recruiting
    • Glioblastoma
    • Recurrent Glioblastoma
    • Boston, Massachusetts
    • +3 more
    Jan 13, 2023

    Advanced Dedifferentiated Liposarcoma, Locally Advanced Dedifferentiated Liposarcoma, Metastatic Dedifferentiated Liposarcoma

    Not yet recruiting
    • Advanced Dedifferentiated Liposarcoma
    • +5 more
    • (no location specified)
    Jan 11, 2023

    Recurrent Skin Squamous Cell Carcinoma, Resectable Skin Squamous Cell Carcinoma, Stage I Skin Cancer Trial in Los Angeles,

    Recruiting
    • Recurrent Skin Squamous Cell Carcinoma
    • +4 more
    • Cemiplimab
    • Resection
    • Los Angeles, California
    • +2 more
    Nov 12, 2022

    NSCLC Trial in Pittsburgh (M1774, Cemiplimab)

    Not yet recruiting
    • Non-Small Cell Lung Cancer
    • Pittsburgh, Pennsylvania
      UPMC Cancer Center
    May 22, 2023

    Lung Cancer Trial in Houston (Cemiplimab, Kevzara (Sarilumab))

    Not yet recruiting
    • Lung Cancer
    • Cemiplimab
    • Kevzara (Sarilumab)
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 19, 2023

    Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck, Resectable Cutaneous Squamous Cell Carcinoma of the Head and

    Recruiting
    • Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck
    • +4 more
    • Cemiplimab
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 17, 2023

    Cutaneous Squamous Cell Carcinoma, Cutaneous Squamous Cell Carcinoma of the Head and Neck Trial in Tucson, Tampa

    Terminated
    Has Results
    • Cutaneous Squamous Cell Carcinoma
    • Cutaneous Squamous Cell Carcinoma of the Head and Neck
    • Tucson, Arizona
    • +1 more
    Nov 2, 2022

    Squamous Cell Carcinoma, Oropharynx Cancer, Head Neck Cancer Trial in Houston (SAR444245, Cemiplimab)

    Not yet recruiting
    • Squamous Cell Carcinoma
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 7, 2022

    Breast Cancer Trial in Ottawa, Toronto (Arm A: Cemiplimab, Arm B: Cemiplimab + Dupilumab)

    Not yet recruiting
    • Breast Cancer
    • Arm A: Cemiplimab, Arm B: Cemiplimab + Dupilumab
    • Ottawa, Ontario, Canada
    • +1 more
    Jul 22, 2023

    Use of Cemiplimab in Adult Patients in UK

    Active, not recruiting
    • Cutaneous Squamous Cell Carcinoma
    • No intervention
    • Reading, Berkshire, United Kingdom
      Sanofi-Aventis UK
    Aug 7, 2022

    Solid Tumor, Adult, Advanced Solid Tumor, Head Neck Cancer Trial in Irving, San Antonio, West Valley City (SNS-101 (anti-VISTA),

    Recruiting
    • Solid Tumor, Adult
    • +19 more
    • SNS-101 (anti-VISTA)
    • Cemiplimab
    • Irving, Texas
    • +2 more
    May 24, 2023

    Locally Advanced Head and Neck Squamous Cell Carcinoma Trial in New York (Cemiplimab, Cisplatin, Docetaxel)

    Recruiting
    • Locally Advanced Head and Neck Squamous Cell Carcinoma
    • Cemiplimab
    • +2 more
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Sep 6, 2022